Virax Biolabs Group Limited VRAX
0.45 USD -0.16 (-26.87%)
Regular-session close
0.43 -0.02 -3.95%
Pre-market · Nov 17, 6:15 AM ET
0.4028 Day range 0.5495
0.4028 52-week range 21.75
- YTD
- -94.82%
- 1 year
- -96.21%
VRAX revenue history
Revenue is income from the company’s ordinary business activities.
12,423 USD
FY 2026 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2026 | 2026-03-31 | 12,423 | 6,092 | 96.22% |
| FY 2025 | 2025-03-31 | 6,331 | -150,088 | -95.95% |
| FY 2024 | 2024-03-31 | 156,419 | 147,858 | 1727.11% |
| FY 2023 | 2023-03-31 | 8,561 | 8,561 | Not meaningful |
| FY 2022 | 2022-03-31 | 0 | -123,820 | -100.00% |
| FY 2021 | 2021-03-31 | 123,820 | 23,944 | 23.97% |
| FY 2020 | 2020-03-31 | 99,876 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-07-11T06:02:23.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
